filgotinib

Full Year Results 2017

Press release
Thursday 22 Feb 22.00 CET
Webcast & teleconference
Friday 23 Feb 14.00 CET

Join our webcast
Dial into TC +32 2 404 0659

Welcome to Galapagos

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biotechnology company, focused on the development and commercialization of novel medicines that will improve people's lives. 

Learn more about Galapagos

News

Loading...

All Galapagos news

Events

Loading...

All Galapagos events

Current Openings

Loading...

All Current Openings